| Anti-inflammatory peptide agonists ET Wei, HA Thomas Annual review of pharmacology and toxicology 33 (1), 91-108, 1993 | 59 | 1993 |
| Peripheral anti‐inflammatory actions of corticotropin‐releasing factor ET Wei, GC Gao, HA Thomas Ciba Foundation Symposium 172‐Corticotropin‐Releasing Factor: Corticotropin …, 2007 | 55 | 2007 |
| Identification of a 185-kDa band 3-related polypeptide in oxyntic cells HA Thomas, TE Machen, A Smolka, R Baron, RR Kopito American Journal of Physiology-Cell Physiology 257 (3), C537-C544, 1989 | 47 | 1989 |
| Regulation of Cl/HCO3 exchange in gastric parietal cells. HA Thomas, TE Machen Cell regulation 2 (9), 727-737, 1991 | 42 | 1991 |
| CRF and related peptides as anti-inflammatory agonists. HA Thomas, N Ling, ET Wei Annals of the New York Academy of Sciences 697, 219-228, 1993 | 38 | 1993 |
| Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues ET Wei, HA Thomas US Patent 5,480,869, 1996 | 36 | 1996 |
| Preclinical profile of PKI166-a novel and potent EGFR tyrosine kinase inhibitor for clinical development. P Traxler, E Buchdunger, P Furet, HP Gschwind, P Ho, H Mett, T O'Reilly, ... Clinical Cancer Research 5, 3750S-3750S, 1999 | 35 | 1999 |
| A new, potent, orally active iron chelator HP Nick, P Acklin, B Faller, Y Jin, R Lattmann, MC Rouan, T Sergejew, ... Iron chelators: new development strategies, 311-333, 2000 | 26 | 2000 |
| D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2β receptors ET Wei, HA Thomas, HC Christian, JC Buckingham, T Kishimoto Peptides 19 (7), 1183-1190, 1998 | 24 | 1998 |
| Anti-inflammatory compositions and method with corticotropin-releasing factor analogs ET Wei, HA Thomas, T Kishimoto US Patent 5,869,450, 1999 | 23 | 1999 |
| Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs ET Wei, HA Thomas European journal of pharmacology 263 (3), 319-321, 1994 | 20 | 1994 |
| Anti-inflammatory composition and method with des-Tyr dynorphin and analogues ET Wei, HA Thomas US Patent 5,482,930, 1996 | 19 | 1996 |
| Anti-inflammatory mystixin peptides inhibit plasma leakage without blocking endothelial gap formation P Baluk, NW Fine, HA Thomas, ET Wei, DM Mcdonald Journal of Pharmacology and Experimental Therapeutics 284 (2), 693-699, 1998 | 17 | 1998 |
| Dynorphin A (6-12) analogs suppress thermal edema ET Wei, HA Thomas, EA Gjerde, RK Reed, SV Burov, VI Korolkov, ... Peptides 19 (4), 767-775, 1998 | 15 | 1998 |
| Novel anti-inflammatory undecapeptides that contain anisolyated glutamic acid derivatives. HA Thomas, N Ling, ET Wei, F Berree, A Cobas, H Rapoport Journal of Pharmacology and Experimental Therapeutics 267 (3), 1321-1326, 1993 | 12 | 1993 |
| Bipolar-shape response of human neutrophils to corticotropin-releasing factor S Iavicoli, E Lopez-Perez, GC Buehring, HA Thomas, ET Wei, T Kishimoto European journal of pharmacology 349 (2-3), 301-306, 1998 | 8 | 1998 |
| Dedicated truck lanes as a solution to capacity and safety issues on interstate highway corridors N Burke, H Thomas, R Crum, J Plazak, J David, S Omar Proceedings of the Midwest Transportation Consortium, 2011 | 6 | 2011 |
| Optic Disc Edema, Globale Flattening, Choroidal Folds, and Hyperopic Shifts Observed in Astronauts after Long—duration Space Flight H Thomas, C Mader, OD Robert, F Anastas American Academy of Ophthalmology Published by Elsevier Inc, 2058-70, 2011 | 6 | 2011 |
| Garnet-orthopyroxene-plagioclase-quartz equilibria: a comparative study H Thomas Gond Geol Magz, advances in Precambrian of Central India, special volume …, 2003 | 5 | 2003 |
| [d-Pro5] Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors ET Wei, HA Thomas, JS Price, T Kishimoto European journal of pharmacology 306 (1-3), 161-164, 1996 | 5 | 1996 |
